Pharma News

Hallstar, a specialty chemical company based in Chicago, has been awarded the 2017 Global in-cosmetics^® Innovation Silver Prize for its revolutionary new anti-aging ingredient, Micah. Winners were announced at the in-cosmetics^® conference in London on April 4th. The awards are given to honor the development of a novel active or functional ingredient combining innovative science and product features in a way that demonstrates substantial benefits to manufacturers and end-users.

[adsense:336x280:8701650588]

The U.S. Food and Drug Administration approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

Parliament passed the bill to ensure equal rights for people living with HIV and AIDS in treatment, employment and admissions to educational institutions.

Intellia Therapeutics a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, announced that the European Patent Office (EPO) has decided to grant a patent broadly covering the CRISPR/Cas9 genome editing technology. The patent includes claims covering compositions of the widely adopted CRISPR single guide RNA technology for use in any non-cellular and cellular setting, including eukaryotic cells such as human or mammalian cells, as well as for use in human therapeutics.

Takeda Pharmaceutical Company Limited announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterology (GI) indications with a high unmet medical need.

[adsense:336x280:8701650588]

The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) unearthed a total of 613 cases of non-compliance of its notified price ceilings of various drugs by companies.

Tobacco use is the leading cause of cancer and death from cancer. In a move to reduce the consumption of tobacco products, the Ministry of Health sought to tax all these products, including bidis, at 28% and impose a higher rate under the new GST regime.

In order to promote competition between public hospitals, Niti Aayog decided to classify district hospitals on the basis of their performance on health indicators. There are about 700 district hospitals across the country to provide secondary health services to people.

In India, oncology treatment generally covers lakhs, particularly with certain lung, prostate and breast cancer drugs evaluated on a lakh per dose in some cases. Regulatory systems, diagnosis, treatment infrastructure and funding mechanisms must be tailored to the needs of patients.